PT-141 10MG

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan II, designed to selectively target melanocortin receptors in the central nervous system. Unlike peripherally-acting compounds, PT-141 works through CNS pathways, making it one of the most studied peptides in sexual function and arousal signaling research — and one of the few melanocortin-based peptides to have received FDA approval in a related formulation.

Mechanism
PT-141 activates melanocortin-4 receptors (MC4R) in the hypothalamus, initiating downstream signaling through dopaminergic and oxytocinergic pathways that influence motivation, desire, and arousal response. Its central mechanism of action distinguishes it from vascular-based compounds and positions it as a unique research tool for studying CNS-driven behavioral responses.

Research Areas: Sexual function & arousal signaling · Melanocortin receptor pharmacology · CNS motivational pathways · Dopamine & oxytocin modulation · Behavioral neuroscience · Neuroendocrine research

For research use only. Not for human consumption.